United States · FDA National Drug Code directory
Zafirlukast
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-008_5d30ffab-38a1-411d-94ad-0a15c227d882
- Product NDC
- 31722-008
- Form
- TABLET, FILM COATED
- Composition / generic term
- Zafirlukast
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200910
- Source listing expiry
- 20261231
Source-listed ingredients
- ZAFIRLUKAST — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 CARTON (31722-008-01) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 31722-008-01
- 500 TABLET, FILM COATED in 1 BOTTLE (31722-008-05) · 31722-008-05
- 60 TABLET, FILM COATED in 1 BOTTLE (31722-008-60) · 31722-008-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →